With over 25 years of experience in cancer biology and immunology research and development, I lead the immuno-oncology discovery efforts at Pfizer. In this role, I define the overarching immuno-oncology strategy and guide the team of talented scientists in the development of novel immunotherapies for solid and liquid tumors, leveraging our expertise in biologics and small molecule modalities. I am passionate about advancing the field of cancer immunology and creating innovative solutions that can improve the lives of patients and their families. I am a strong believer in collaboration, innovation, and excellence, and I strive to foster a culture of curiosity, diversity, and impact in my team and organization.